Atea Pharmaceuticals Inc. (AVIR)
NASDAQ: AVIR
· Real-Time Price · USD
3.50
0.01 (0.29%)
At close: Aug 15, 2025, 3:59 PM
3.50
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT
Atea Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 87.72M | 119.39M | 64.7M | 98.46M | 243.39M | 160.91M | 143.82M | 137.89M | 213.7M | 183.25M | 646.71M | 176.41M | 684.48M | 705.54M | 764.38M | 839.66M | 816.46M | 833.75M |
Short-Term Investments | 291.99M | 306.04M | 390.02M | 384.35M | 258.82M | 380.58M | 434.28M | 457.24M | 394.36M | 437.23M | 458.25M | 488.56M | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 198K | 198K | 198K | n/a | 305K | 305K | 305K | n/a | n/a | n/a |
Other Long-Term Assets | 4.39M | 4.39M | 197K | 1.68M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.69M | 1.49M | 305K | n/a | n/a | 161K | 532K | 400K | 463K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.51M | n/a | n/a | n/a | n/a | 50M | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.89M | 8.27M | 7.63M | 4.09M | 4.16M | 7.27M | 12.35M | 8.19M | 12.76M | 11.9M | 14.21M | n/a | 4.97M | 7.69M | 8.03M | 3.29M | 4.65M | 6.39M |
Total Current Assets | 385.6M | 433.71M | 462.36M | 486.91M | 506.37M | 548.76M | 590.46M | 603.32M | 620.83M | 632.39M | 660.92M | 681.93M | 689.45M | 713.23M | 772.4M | 842.95M | 871.11M | 840.14M |
Property-Plant & Equipment | 1.61M | 1.86M | 2.12M | 2.37M | 2.62M | 2.87M | 3.12M | 3.36M | 3.61M | 3.85M | 4.09M | 4.34M | 4.58M | 3.65M | 23K | 26K | 33K | 41K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 6M | 6.26M | 2.31M | 4.05M | 4.01M | 4.26M | 4.51M | 4.76M | 5.2M | 5.74M | 5.79M | 4.64M | 4.89M | 3.96M | 489K | 558K | 433K | 504K |
Total Assets | 391.61M | 439.96M | 464.67M | 490.96M | 510.38M | 553.03M | 594.97M | 608.08M | 626.03M | 638.13M | 666.71M | 686.58M | 694.34M | 717.19M | 772.89M | 843.5M | 871.54M | 840.65M |
Account Payables | 8.84M | 7.39M | 4.46M | 5.79M | 5.47M | 21.14M | 4.25M | 395K | 3.96M | 700K | 2.55M | 1.12M | 13.88M | 3.66M | 4.53M | 22.19M | 10.7M | 3.79M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.49M | n/a | n/a | -711K | n/a | n/a | -197K | 192.18M | 224.99M | 235.38M |
Short-Term Debt | 821K | n/a | n/a | n/a | n/a | 769K | 760K | 750K | 740K | 730K | n/a | 711K | 730K | 113K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 6.73M | n/a | 7.44M | n/a | 16.18M | -769K | 20.91M | -750K | 6.93M | 7.62M | 8.65M | 8.7M | 6.53M | 22.81M | 45.37M | 44.5M | 29M | 14.28M |
Total Current Liabilities | 20.12M | 21.75M | 18.6M | 25.19M | 26.62M | 41.31M | 32.38M | 18.89M | 16.16M | 12.36M | 18.48M | 15.63M | 25.11M | 28.61M | 56.88M | 262.05M | 273.65M | 254.28M |
Long-Term Debt | 425K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 6.64M | 6.5M | 6.36M | 6.2M | 6.05M | 5.9M | 5.76M | 5.62M | 5.49M | 5.37M | 5.25M | 5.17M | 6.01M | 5.93M | 5.93M | n/a | n/a | 113K |
Total Long-Term Liabilities | 7.07M | 7.13M | 7.2M | 7.25M | 7.29M | 7.35M | 7.4M | 7.45M | 7.52M | 7.59M | 7.66M | 7.75M | 8.77M | 8.7M | 5.93M | n/a | 29K | 113K |
Total Liabilities | 27.19M | 28.88M | 25.8M | 32.44M | 33.91M | 48.66M | 39.78M | 26.34M | 23.68M | 19.95M | 26.14M | 23.39M | 33.88M | 37.3M | 62.81M | 262.05M | 273.68M | 254.39M |
Total Debt | 1.25M | 1.45M | 1.64M | 1.83M | 2.02M | 2.21M | 2.4M | 2.58M | 2.77M | 2.94M | 3.12M | 3.3M | 3.5M | 2.88M | 197K | 279K | 361K | 113K |
Common Stock | 81K | 85K | 84K | 84K | 84K | 84K | 83K | 83K | 83K | 83K | 83K | 83K | 83K | 83K | 83K | 83K | 83K | 83K |
Retained Earnings | -435.65M | -398.49M | -364.22M | -330.68M | -299.53M | -259M | -195.84M | -156.67M | -123.53M | -95.35M | -59.88M | -25.45M | -17.38M | 13.95M | 56.03M | -61.1M | -32.91M | -34.45M |
Comprehensive Income | 37K | 118K | 233K | 641K | -280K | -181K | 207K | -262K | -310K | -307K | -684K | -855K | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 |
Shareholders Equity | 364.42M | 411.08M | 438.87M | 458.52M | 476.47M | 504.37M | 555.19M | 581.73M | 602.35M | 618.18M | 640.57M | 663.19M | 660.46M | 679.88M | 710.08M | 581.45M | 597.86M | 586.26M |
Total Investments | 291.99M | 306.04M | 390.02M | 384.35M | 258.82M | 380.58M | 434.28M | 457.24M | 394.36M | 437.23M | 458.25M | 488.56M | 305K | 305K | 305K | n/a | n/a | n/a |